Composition : Montelukast 4mg, 5mg,10mg & 10mg chewable tablet.
Indications : M-Kast is indicated for the prophylaxis and chronic treatment of asthma.
Dosage and administration : Adolescents & adults (15 years of age or over) : 10mg daily to be taken in the evening.
Pediatric (6-14 years of age) : 5mg daily to be taken in the evening.
Pediatric (2-5 years of age) : 4mg daily to be taken in the evening.
Safety and effectiveness of Montelukast in pediatric patients less than 12 months of age with asthma have not been established. Or, as directed by the registered physician.
Side effects : Generally, Montelukast is well-tolerated. Side effects include dizziness, headache, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.
Contraindication :
Montelukast is contraindicated to patients with hypersensitivity to any component of this product.
Precautions : Montelukast is not indicated in acute asthma attacks. Patients with known aspirin sensitivity should avoid aspirin or other NSAID, while taking Montelukast.
Use in pregnancy and lactation :
Montelukast has been assigned to pregnancy category B by the FDA.
Drug interaction : Montelukast has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no appropriate increase in adverse reactions.
Cytochrome P-450 inducers : No dosage adjustment for Montelukast is recommended.
Packing :
M-Kast 4 : 2×14’s tablets in blister pack.
M-Kast 5 : 2×14’s tablets in blister pack.
M-Kast 10 : 2×10’s tablets in blister pack.
M-Kast 10-C : 2×14’s tablets in blister pack.